Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|7|1|196-207

ISSN： 2045-7634

Source： Cancer Medicine, Vol.7, Iss.1, 2018-01, pp. : 196-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells

By Du Hailei   Yang Weiping   Chen Lin   Shi Mingming   Seewoo Varun   Wang Jiayu   Lin Andy   Liu Zhuoran   Qiu Weihua  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 143-150

Spandidos Publications

Access to resources Recommend Favorite

Anticancer Effect of PS-T on the Experimental Hepatocellular Carcinoma

By Chen Li   Lu Peng   Lu Zhengxin   Li Dechun  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 55-59

Springer Publishing Company

Access to resources Recommend Favorite

Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells

By                

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1570-1576

Spandidos Publications

Access to resources Recommend Favorite

Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells

By Du Qin   Hu Bing   An Hong-Mei   Shen Ke-Ping   Xu Ling   Deng Shan   Wei Meng-Meng  

Oncology Reports, Vol. 29, Iss. 5, 2013-05 ,pp. : 1851-1858

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling

By              

International Journal of Oncology, Vol. 45, Iss. 1, 2014-01 ,pp. : 177-188

Spandidos Publications

Access to resources Recommend Favorite